Liposome-Based Microarray for High-Throughput Lipid Spotting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current microarray technologies face challenges in constructing high-throughput lipid arrays due to the solubility of lipids in organic solvents, which existing spotting devices are not designed to handle, limiting the production of lipid microarrays for biomedical applications.
Innovation Solution
The development of a method to spot lipid vesicles, such as liposomes, on nitrocellulose-coated slides using existing cDNA microarray spotting technology, allowing for the creation of lipid microarrays that maintain antigenic structure and are resistant to aqueous solutions, enabling the use of lipids in microarray construction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If existing cDNA microarray spotting technology is used to spot lipids, then the production process can be maintained, but the solubility of lipids in organic solvents prevents successful spotting
Solution Approach 1:
The patent changes the physical state of lipids from dissolved organic solution to suspended aqueous dispersion. By transforming lipids into liposomes or lipid vesicles that can be suspended in water, the patent enables compatibility with aqueous-based spotting technology while maintaining lipid integrity and antigenic structure.
Solution Approach 2:
The patent introduces an intermediary formulation system where lipids are encapsulated in liposomes or vesicles. This intermediary structure acts as a bridge between the hydrophobic lipid molecules and the hydrophilic aqueous spotting environment, enabling successful transfer of lipids to the microarray substrate without requiring organic solvents.
2Ease of operation
If lipids are spotted directly without forming vesicles, then the spotting process is simpler, but the antigenic structure is not preserved and the arrays are not resistant to aqueous solutions
Solution Approach 1:
The patent uses liposomal vesicles as flexible shells that encapsulate and protect lipid antigens. These vesicular structures maintain the three-dimensional conformation and antigenic epitopes of embedded lipids while providing resistance to aqueous environments, enabling both simple spotting and reliable antigen preservation.
Solution Approach 2:
The patent employs a nested structure where lipid antigens are embedded within the bilayer membrane of liposomes. This nested arrangement protects the antigenic lipids from degradation while maintaining their structural integrity and immunogenicity, allowing them to withstand aqueous spotting conditions.
3Productivity
If high-throughput production is implemented, then productivity increases, but the handling of organic solvent-based lipid solutions becomes more difficult
Solution Approach 1:
The patent employs self-assembling liposomal vesicles that automatically form when lipids are exposed to aqueous environments. This self-service mechanism eliminates the need for complex organic solvent handling and purification steps, enabling high-throughput automated spotting while maintaining lipid integrity and reducing manufacturing complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the construction of stable lipid microarrays that preserve antigenic reactivities, facilitating the characterization of lipid-antibody interactions and allowing for high-throughput production suitable for biomedical applications.
Implementation Method 1
The development of a method to spot lipid vesicles, such as liposomes, on nitrocellulose-coated slides
Implementation Method 2
spotting devices are not designed to handle [organic solvents], limiting the production of lipid microarrays
Data Source
AI summary
This invention provides novel liposome-based articles of manufacture and microarrays and methods of making and using them (1) to detect the presence of one or more agents in a sample, (2) to determine the amount of one or more agents in a sample, and (3) to determine whether a subject is afflicted with a disorder. This invention also provides kits which comprise the instant microarrays.